| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology2 Department of Internal Medicine (Division II)3 Central Research Laboratory (Nakahari Project), Osaka Medical College, 2-7 Daigakucho, Takatsuki 569-8686, Japan
Ca2+-regulated exocytosis is enhanced by an autocrine mechanism via the PGE2–cAMP pathway in antral mucous cells of guinea-pigs. The inhibition of the PGE2–cAMP pathway by H-89 (an inhibitor of protein kinase A, PKA) or aspirin (ASA, an inhibitor of cyclo-oxygenase, COX) decreased the frequency of ACh-stimulated exocytotic events by 60%. Indomethacin (IDM, an inhibitor of COX), however, decreased the frequency of ACh-stimulated exocytotic events only by 30%. Moreover, IDM increased the frequency of ACh-stimulated exocytotic events by 50% in H-89-treated or ASA-treated cells. IDM inhibits the synthesis of Prostaglandin (PGG/H) and (15R)-15-hydroxy-5,8,11 cis-13-trans-eicosatetraenoic acid (15R-HPETE), while ASA inhibits only the synthesis of PGG/H. Thus, IDM may accumulate arachidonic acid (AA). AACOCF3 or N-(p-amylcinnamoyl) anthranilic acid (ACA; both inhibitors of phospholipase A2, PLA2), which inhibits AA synthesis, decreased the frequency of ACh-stimulated exocytotic events by 60%. IDM, however, did not increase the frequency in AACOCF3-treated cells. AA increased the frequency of ACh-stimulated exocytotic events in AACOCF3- or ASA-treated cells, similar to IDM in ASA- and H-89-treated cells. Moreover, in the presence of AA, IDM did not increase the frequency of ACh-stimulated exocytotic events in ASA-treated cells. The PGE2 release from antral mucosa indicates that inhibition of PLA2 by ACA inhibits the AA accumulation in unstimulated and ACh-stimulated antral mucosa. The dose–response study of AA and IDM demonstrated that the concentration of intracellular AA accumulated by IDM is less than 100 nM. In conclusion, IDM modulates the ACh-stimulated exocytosis via AA accumulation in antral mucous cells.
(Received 6 October 2005;
accepted after revision 1 November 2005; first published online 1 November 2005)
Corresponding author T. Nakahari: Department of Physiology, Osaka Medical College, 2-7 Daigakucho, Takatsuki 569-8686, Japan. Email: takan{at}art.osaka-med.ac.jp
This article has been cited by other articles:
|
|
 |
|
  C. Shimamoto, E. Umegaki, K.-i. Katsu, M. Kato, S. Fujiwara, T. Kubota, and T. Nakahari [Cl ]i modulation of Ca2+-regulated exocytosis in ACh-stimulated antral mucous cells of guinea pig Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G824 - G837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. De Vuyst, E. Decrock, M. De Bock, H. Yamasaki, C. C. Naus, W. H. Evans, and L. Leybaert Connexin Hemichannels and Gap Junction Channels Are Differentially Influenced by Lipopolysaccharide and Basic Fibroblast Growth Factor Mol. Biol. Cell, January 1, 2007; 18(1): 34 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shimamoto, Y. Nakanishi, K.-i. Katsu, T. Nakano, T. Kubota, H. Mori, and T. Nakahari Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1 Exp Physiol, November 1, 2006; 91(6): 1015 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Saad, C. Shimamoto, T. Nakahari, S. Fujiwara, K.-i. Katsu, and Y. Marunaka cGMP modulation of ACh-stimulated exocytosis in guinea pig antral mucous cells Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1138 - G1148. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
